Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Dusseldorf - Delayed Quote EUR

Cue Biopharma Inc (1UC.DU)

Compare
0.6190
+0.0280
+(4.74%)
As of 12:30:18 PM GMT+2. Market Open.
Loading Chart for 1UC.DU
  • Previous Close 0.5910
  • Open 0.6260
  • Bid 0.6190 x --
  • Ask 0.6500 x --
  • Day's Range 0.6180 - 0.6260
  • 52 Week Range 0.3180 - 2.0200
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 1UC.DU

View More

Performance Overview: 1UC.DU

Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

1UC.DU
34.15%
S&P 500 (^GSPC)
10.43%

1-Year Return

1UC.DU
60.32%
S&P 500 (^GSPC)
1.33%

3-Year Return

1UC.DU
63.80%
S&P 500 (^GSPC)
19.39%

5-Year Return

1UC.DU
63.80%
S&P 500 (^GSPC)
88.83%

Compare To: 1UC.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 1UC.DU

View More

Valuation Measures

Annual
As of 4/10/2025
  • Market Cap

    40.58M

  • Enterprise Value

    28.18M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.93

  • Price/Book (mrq)

    2.29

  • Enterprise Value/Revenue

    3.32

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 1UC.DU

View More

Company Insights: 1UC.DU

Research Reports: 1UC.DU

View More